Press release
Cardiovascular Drugs Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2023
Cardiovascular Drugs Market
Market Outline: Cardiovascular Drugs Market
Cardiovascular drugs are the medications used in the treatment of various cardiovascular diseases. Cardiovascular diseases (CVD) include coronary artery diseases (CAD), myocardial infarction, angina pectoris, hypertension, cardiomyopathy, congenital heart disease, cardiac arrhythmia, peripheral artery diseases, atherosclerosis, and venous thrombosis among others. Majority of the cardiovascular diseases are preventable with cardiovascular drugs, however, in frequent conditions death may occur due to cardiovascular diseases.
A sample of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/cardiovascular-drugs-market/#ulp-4H8Z4LpNMLEuOnnx
Market Dynamics: Cardiovascular Drugs Market
Increase in the prevalence of cardiovascular diseases, for instance, according to World health organization 2015, approximately 17.7 Mn people died from cardiovascular diseases around the globe, rise in R&D activities for the innovation of newer cardiovascular drugs, government support to increase the awareness about the cardiovascular diseases and treatment are anticipated to fuel the cardiovascular drugs market. Moreover, change in lifestyle, promising product pipeline, rise in prevalence of obesity, and wider access to cardiovascular drugs in the market are anticipated to propel the market. However, stringent regulatory guidelines for the product approval, high cost of treatment, and adverse effects associated with the medications are hampering the growth of cardiovascular drugs market.
Market Scope: Cardiovascular Drugs Market
Cardiovascular drugs market is segmented on the basis of indication, drug class, route of administration, distribution channel, and region
Based on the indication, the market is segmented into the following:
• Hypertension
• Congestive Heart disease
• Angina pectoris
• Myocardial Ischemia
• Peripheral Artery Diseases
• Atherosclerosis
• Cardiomyopathy
• Others
Based on the drug class, the market is segmented into the following:
• Calcium Channel Blockers
• Angiotensin Converting Enzyme (ACE) inhibitors
• Angiotensin-II Receptor antagonists
• Diuretics
• Lipid-lowering drugs
• Beta-adrenergic Blocking Agents
• Vasodilators
• Anti-platelet Agents
• Others
Based on the route of administration, the market is segmented into the following:
• Oral
• Buccal/sublingual
• Intravenous
• Oral
• Others
Based on distribution channel, the market is segmented into the following:
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
Based on region, the market is segmented into the following:
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa
To view TOC of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/cardiovascular-drugs-market/#ulp-c654SbFYO64MsOhu
Market Summary: Cardiovascular Drugs Market
Global cardiovascular drugs market has tremendous growth rate over the forecast years owing to increase in the prevalence of various cardiovascular diseases and rise in R&D activities for the innovation of newer drugs. According to World Health Organization 2015, approximately 17.7 Mn deaths occured due to cardiovascular diseases around the world. Moreover, government support to control the diseases, rise in funding from public and private sectors for the R&D activities, and patent expiration of blockbuster are bolster the cardiovascular drugs market. Furthermore, acquisitions and mergers, product approvals, and promising pipeline drugs might upsurge the revenue of cardiovascular drugs market. For instance, in November 2015, AstraZeneca acquired ZS Pharma to strengthen its cardiovascular drugs portfolio by developing novel treatment for hyperkalemia, typically associated with chronic heart failure (CHF). In addition, in June 2016, Espero Pharmaceuticals received FDA approval for Gonitro (Nitroglycerin) sublingual powder used for acute relief of an angina pectoris attack due to coronary artery disease.
Regional Analysis: Cardiovascular Drugs Market
Geographically, global cardiovascular drugs market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America cardiovascular drugs market accounted for significant share owing to increase in the prevalence of cardiovascular diseases (according to centers for Disease Control and Prevention, approximately 610,000 deaths occur due to various heart diseases in U.S. every year) and rise in R&D activities in North America region. Europe cardiovascular drugs market exhibiting lucrative growth due to increase in incidences of cardiovascular diseases majorly in Germany, Russia, UK, Ukraine, and Italy. Asia Pacific cardiovascular drugs market is growing at notable rate due to increase in geriatric population in India, China, and Japan, rise in medical tourism in Asia Pacific countries, and government support for the prevention of cardiovascular diseases in various countries. Latin America cardiovascular drugs market has significant growth which is attributed to increase in prevalence of cardiovascular diseases in Chile, Argentina, and Brazil. Middle East and Africa cardiovascular drugs market is growing due to expansion of business by market players, rise in prevalence of cardiovascular diseases, and government support to protect the public health.
Need more information about this report @
https://www.precisionbusinessinsights.com/market-reports/cardiovascular-drugs-market/#ulp-14mlyhjMGhVjZqa3
Competition Assessment: Cardiovascular Drugs Market
Some of the players in the global cardiovascular drugs market include:
• AstraZeneca plc (U.K.)
• GlaxoSmithKline plc (U.K.)
• Novartis AG (Switzerland)
• Bristol Myers Squibb (U.S.)
• Pfizer, Inc. (U.S.)
• Sanofi S.A. (France)
• Boehringer Ingelheim GmbH (Germany)
• Johnson & Johnson Services, Inc. (U.S.)
• Bayer AG (Germany)
• Merck & Co., Inc. (U.S.)
• Espero Pharmaceuticals, Inc. (U.S.)
Notable Market Developments: Cardiovascular Drugs Market
• In February 2017, Pfizer, Inc. and Washington University collaborated to develop newer drugs in certain therapeutic areas include cardiovascular diseases
Key Features of the Report:
• The report provides granular level information about the market size, regional market share, historic market (2012 to 2016) and forecast (2017 to 2023)
• The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
• The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
• The report tracks recent innovations, key developments and startup’s details that are actively working in the market
• The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
• The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/cardiovascular-drugs-market/
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth.
Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights
Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cardiovascular Drugs Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2023 here
News-ID: 1000752 • Views: …
More Releases from Precision Business Insights
Biochar Market Growth Is Attributed To The Increased Production Of Biochar Throu …
According to Precision Business Insights (PBI), the latest report biochar market was valued at USD 243.8 million in 2022, growing at a 12.6% CAGR during the forecast period 2023 to 2029. The rising demand for organic and eco-friendly products drives the biochar market. Utilizing biochar corresponds with organic farming methods, improving market prospects. Furthermore, biochar is a potential material for water treatment and remediation because of its capacity to absorb…
Vapor Recovery Units Market Growth Is Attributed To The Increased Adoption Of Me …
According to Precision Business Insights (PBI), latest report vapor recovery units market was valued at USD 923.7 million in 2022 and is poised to grow at a CAGR of 4.2% during the forecast period 2023 to 2029. The adoption of stringent environmental regulations by governments and international bodies to reduce air pollution and greenhouse gas emissions in various countries drives the demand for the vapor recovery unit's market. Furthermore, the…
Pyrite Market Growth Is Attributed To The Increased Demand In Jewelry Industry
According to Precision Business Insights (PBI), latest report pyrite market is growing at 4.9% CAGR during the forecast period 2023 to 2029. The increased application of pyrite in the manufacturing of sulfuric acid drives the pyrite market. The increase of prices of gold has led to increased demand for imitation jewelry which is anticipated to propel the pyrite market growth. Furthermore, the demand for sulphuric acid in a variety of…
Industrial Boilers Market Growth Is Attributed To The Increased Use In Power Gen …
According to Precision Business Insights (PBI), the latest report industrial boilers market size was valued at USD 15,261.8 million in 2022 and is poised to grow at a 3.1% CAGR during the forecast period 2023 to 2029. The adoption of stringent environmental regulations to maintain emission standards and carbon reduction in several countries drives the industrial boilers market. Furthermore, the advancement in boiler technology, such as better combustion systems, greater…
More Releases for Cardiovascular
Increasing Prevalence of Cardiovascular Diseases to Augment the Cardiovascular I …
Cardiovascular information system offers on-time access to cardiovascular electronic medical records in reports, images, and waveforms, and allows easy report generation and distribution. Cardiovascular information system is extensively used in electrocardiography (ECG) data management, echocardiography, catheterization, and vascular solutions.
Click Here To Get Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/20
Cardiovascular information system is used to store, archive, and share healthcare information. It is a unique software solution that helps improve the clinical and financial…
Global Cardiovascular Drugs Market
Global Cardiovascular Drugs Market – Industry Analysis and Forecast (2018-2026) – by Drug Class, Indications, Distribution Channels, and Region.
Global Cardiovascular Drugs Market was valued at US$ 80.5 Bn in 2017 and is expected to reach US$ 98.8 Bn by 2026, at a CAGR of 2.6 % during the forecast period.
The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data,…
Mexico Cardiovascular Devices Market Outlook to 2025 Cardiac Assist Devices, Car …
Orbisresearch.com has announced the addition of Mexico Cardiovascular Devices Market. The report focuses on global major leading industry players with information such as company profiles, product picture and specification.
Mexico Cardiovascular Devices Market Outlook to 2025, provides key market data on the Mexico Cardiovascular Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market categories - Cardiac Assist Devices, Cardiac Rhythm…
Cardiovascular Drugs Market | Insights
Some of the common cardiovascular diseases include hypertensive heart disease, rheumatic heart disease, ischemic heart disease, inflammatory heart disease, and cerebrovascular heart disease. Major problems associated with hypertensive heart disease include angina, hypertrophy, and heart failure. These problems are caused due to high blood pressure in the heart’s arteries and muscles, which causes narrowing of arteries and thickening and enlargement of heart. The global cardiovascular drug market is primarily driven…
Increasing Cardiovascular Surgeries Leads To Higher Market Value For Cardiovascu …
When a coronary artery is narrowed by the accumulation of fatty acids, also known as plaque, the blood flow to heart is reduced which result in the chest pain and if the blockage increases the blood flow to the heart is further reduced and might lead to cardiac arrest. To reduce the chances of heart attack, a tiny wire mesh tube is inserted in the artery with a balloon catheter,…
Cardiovascular Monitoring and Diagnostic Devices Market to be Driven with the Ri …
The global market for cardiovascular monitoring and diagnostic devices is expected to expand at a healthy CAGR of 6.4% over the period between 2016 and 2024, rising from a valuation of US$1.8 bn in 2015 to US$3.1 bn by 2024. The segment of ECG systems contributed the largest share to the market’s overall revenues in 2015, accounting for nearly US$878 mn in 2015. However, the segment of implantable loop recorder…
